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Objectives: Health-related quality of life (HRQoL) is one of the most important outcome measures for 
patients. The purpose of this study was to evaluate HRQoL and related factors in Coronavirus disease 
2019 (COVID-19) patients.
Methods: A total of 420 COVID-19 patients who had been discharged from hospital were selected using a 
systematic sampling. The EuroQol 5-dimensional-5 levels (EQ-5D-5L) questionnaire along with medical 
records of the patients were used to gather the data. The t test and analysis of variance were employed 
to test the difference between mean EQ-5D-5L scores, and the BetaMix model was used to investigate 
factors associated with EQ-5D-5L scores.
Results: The mean score for the patients who completed the EQ-5D-5L questionnaire (n = 409) was 
0.6125. The EQ-5D-5L scores were significantly higher in males, patients with younger age , those 
with a low level of education, the employed, patients who worked in uncrowded workplaces, patients 
without diabetes, and those who were not admitted to intensive care unit. The BetaMix model showed 
that gender, age, education, employment status, having diabetes, heart failure, and admission to the 
intensive care unit were significant independent predictors of the EQ-5D-5L index values.
Conclusion: The mean score for EQ-5D-5L in COVID-19 patients was low in this study. Some of the 
factors, especially aging and having diabetes, should be considered in the aftercare of patients to 
improve their HRQoL.
©2020 Korea Disease Control and Prevention Agency. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Coronavirus disease 2019 (COVID-19) is a new infectious 
disease that was first discovered in Wuhan, China, on the 31st 
December 2019 [1]. It has subsequently spread to almost all 
countries around the world. According to the latest report by 
the World Health Organization (April 25th, 2020), this disease 
has spread to 210 countries and territories around the world, 
and 2 international conveyances [2]. Iran, with more than 
100,000 cases of COVID-19, and a deaths-to-infections ratio 
of 6.4%, is amongst the highest ranked countries in terms of 
outbreak and mortality [2]. The spread of COVID-19 through 
all 31 provinces of Iran was very rapid (less than a month) [3]. 
Yazd, located in center of Iran, had more than 1,500 confirmed 
cases of COVID-19 in Iran in June 2020. 
COVID-19 is a serious disease that can significantly affect 
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the daily lives of recovered patients and their families in terms 
of mental health problems such as post-traumatic stress [4], 
depression [5], anxiety [6] and insomnia [7], as well as the 
negative impact COVID-19 has on patients quality of life (QoL) 
[8]. Since the patients are not immune to future infection 
[9], it may lead to a more negative impact on patients’ QoL. 
Health-related quality of life (HRQoL) is an important measure 
that is used for assessing the impact of diseases, disorders, 
or disabilities on the physical, mental, and social domains of 
patient health. The assessment of HRQoL helps healthcare 
providers identify the factors affecting QoL and recognize the 
aspects of COVID-19 management that needs to be enhanced 
for improving the QoL of patients [10,11].
The EuroQol 5-dimensional-5 levels (EQ-5D-5L) questionnaire 
is one of the most commonly used instruments for measuring 
HRQoL in clinical and outcome research, and its use is 
recommended by the National Institute for Health and Clinical 
Excellence [12,13]. This instrument was translated into Persian 
and was confirmed by the EuroQol group [14]. This study used 
the EQ-5D-5L instrument to describe the HRQoL of COVID-19 
patients who had been discharged from the only hospital 
dedicated to COVID-19 patients in Yazd, and assessed the 
impact of socio-demographic and clinical factors on COVID-19 
patients’ HRQoL. 
Materials and Methods
1. Study design and data collection
This cross-sectional study was conducted in COVID-19 
patients who had been discharged from the Shahid Sadoughi 
hospital (dedicated to the treatment of patients with COVID-19 
in Yazd). According to the medical records of COVID-19 
patients, a total of 420 patients were selected in systematic 
sampling in March 2020. 
The EQ-5D-5L questionnaire, along with socio-demographic 
characteristics, were completed for patients during a telephone 
interview. Clinical data were extracted from the medical 
records of patients. Oral consent was obtained from all patients 
before participating in the study. All procedures performed 
were in accordance with the ethical standards of the national 
research committee (approval no.: IR.BUMS.REC. 1399.109)  
2. EQ-5D-5L instrument
The EQ-5D-5L is a common instrument to assess HRQoL 
(developed by the EuroQol group in 2011) [15]. The EQ-5D-
5L includes 5 dimensions (mobility, self-care, usual activities, 
pain/discomfort, and anxiety/depression). Each of the 
dimensions has 5 levels of response options (no problems, 
slight problems, moderate problems, severe problems, and 
unable to/extreme problems) to define all possible health 
states. In addition, the EQ-5D-5L questionnaire has a visual 
analog scale measured on a vertical line to determine 
the overall health status of the respondents [0 (the worst 
imaginable health) to 100 (the best imaginable health)] [16]. 
The Iranian interim EQ-5D-5L value set (generated through 
the crosswalk technique introduced by the EuroQoL group [17]), 
and the interim value set confirmed by 2 studies in Iran [18,19] 
were used in this current study. This technique generated the 
value set for the EQ-5D-5L by making a correlation between 
the EQ-5D-5L and the EQ-5D-3L descriptive systems.
3. Statistical analysis
Given that the distribution of EQ-5D data is commonly 
skewed, multimodal, and is limited at the top and the bottom, 
and it often has a large number of observations at the top 
(ceiling effects), use of  basic models such as ordinary least 
squares (OLS) and Tobit is theoretically inappropriate for 
analysis of such data [20]. Recently, 2 new mixture models 
were developed to deal with the distributional characteristics 
of the EQ-5D instrument [adjusted limited dependent variable 
mixture model and extensions to a beta mixture model 
(BetaMix model)]. In this study, the betamix command was 
used for assessing the factors affecting HRQoL.
Data was not normally distributed (using the Kolmogorov–
Smirnov test) however, the t test and ANOVA were used in 
this study because parametric tests had the same results as 
nonparametric tests.  All analyses were performed using Stata\
Version 15.0 for Windows (StataCorp, College Station, TX, USA).
Results
Out of 420 interviews, 11 interviews were excluded from the 
final analysis because data on many of the dimensions of the 
EQ-5D-5L questionnaire were not available. Table 1 shows the 
socio-demographic and clinical characteristics of patients. The 
mean age of patients was 58.4 ± 18.21 years, and the average 
of household occupancy was 2.10 ± 0.18. Among COVID-19 
patients, the majority were males, aged 51 to 60 years, married, 
unemployed, with a primary level of education, and in a 
household of between 1 to 2 members, and those who worked 
did so in a crowded environment.
The clinical characteristics of patients are presented in Table 
2. The mean duration of hospitalization and days following 
hospital discharge was 8 ± 7 and 21.6 ± 14.8 days, respectively. 
The majority of COVID-19 patients had a hospital duration of ≤ 10 
days and the duration of days following hospital discharge was 
> 30 days. In this study, 30% of the patients who were treated 
in the intensive care unit (ICU) were more than 60 years old.
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1. Distribution of the EQ-5D-5L dimensions 
The distribution of HRQoL problems reported by patients 
for each of the EQ-5D-5L dimensions is shown in Figure 1. The 
percentage of patients reporting no problems (healthy state) 
for mobility, self-care, usual activities, pain/discomfort, and 
anxiety/depression was 53.34%, 87.75%, 58.97%, 57.97%, and 
41.26%, respectively. Patients only reported unable to/extreme 
problems for the anxiety dimension. 
2. Univariate analyses
The mean EQ-5D-5L index values for patients were 
0.6125 ± 0.006. The results of univariate analysis for the 
association between socio-demographic factors and the EQ-
5D-5L index values are presented in Table 1. The difference 
between the mean EQ-5D-5L index values was significant 
for gender (p = 0.002), age (p = 0.005), education status (p < 
0.001), employment status (p < 0.001), and workplace status 
Variable n (%) Mean EQ-5D-5L index (SD) T F p
Gender
   Male 247 (60.27) 0.628 (0.201) 2.738 0.002*
   Female 162 (39.73) 0.585 (0.198)
Age group (y)
   ≤ 40 27 (6.60) 0.618 (0.321) 4.270 0.005†
   41-50 108 (26.40) 0.602 (0.298) -
   51-60 167 (40.84) 0.581 (0.192)
   > 60 107 (26.16) 0.554 (0.145)
Education status
   Illiterate 18 (4.40) 0.601 (0.178) - 5.533 < 0.001†
   Primary 130 (41.56) 0.615 (0.174)
   Secondary 237 (48.17) 0.575 (0.201)
   University degree 24 (5.87) 0.546 (0.206)
Marital status
   Single    2 (0.49) 0.618 (0.157) - 3.124 0.2051†
   Married 357 (87.29) 0.615 (0.121)
   Divorced or widow   50 (12.22) 0.602 (0.271)
Household occupancy
   ≤ 2 282 (68.94) 0.610 (0.431) 1.21 0.541*
   > 2 127 (31.06) 0.606 (0.576)
Employment status
   Employed 187 (45.72) 0.623 (0.167) 4.35 < 0.001†
   Unemployed 222 (58.28) 0.592 (0.201)
Workplace status
   Uncrowded 130 (31.79) 0.613 (0.187) 2.98 0.002†
   Crowded 279 (68.21) 0.597 (0.132)
EQ-5D-5L = EuroQol -5 dimensions - 5 levels.
* Statistical significance of differences calculated using t test.
† Statistical significance of differences calculated using ANOVA.
Table 1. Socio-demographic characteristics and the EQ-5D-5L index values (N = 409).
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n (%) mean EQ-5D-5L index (SD) T F p
Duration of hospitalization (d)
   ≤ 10 222 (58.28) 0.591 (0.201) 1.91 0.064*
   > 10 187 (45.72) 0.603 (0.167)
Duration after hospital discharge (d)
   ≤ 14 34 (8.31) 0.602 (0.157) 2.97 0.674†
   15-30 168 (41.07) 0.611 (0.271)
   > 30 207 (50.61) 0.608 (0.121)
Admission ward
   ICU admission   74 (18.09) 0.581 (0.201) 3.97 < 0.001*
   No ICU admission 335 (81.91) 0.613 (0.167)
Comorbidities
   Diabetes (Yes) 262 (64.06) 0.586 (0.121) 3.41 < 0.001*
   Diabetes (No) 147 (35.94) 0.612 (0.107)
   Heart failure (Yes) 45 (11.00) 0.597 (0.157) 2.13 0.002*
   Heart failure (No) 364 (89.00) 0.605 (0.131)
   Cholesterol (Yes) 212 (51.83) 0.608 (0.101) 1.89 0.078*
   Cholesterol (No) 197 (48.17) 0.612 (0.167)
   Hypertension (Yes) 245 (59.90) 0.598 (0.167) 1.76 0.089*
   Hypertension (No) 164 (40.10) 0.609 (0.201)
EQ-5D-5L= EuroQol -5 dimensions - 5 levels; ICU= intensive care unit.
* Statistical significance of differences calculated using t test.
† Statistical significance of differences calculated using ANOVA.
Table 2. Clinical characteristics and the EQ-5D-5L index values (N = 409).
(p = 0.002). Univariate analysis also showed that among clinical 
factors, the difference between the mean EQ-5D-5L index 
values was significant if the patient had diabetes (p < 0.001), or 
heart failure (p = 0.002) and/or was admitted to hospital (p < 
0.001).  
3. Regression analyses 
The factors associated with HRQoL scores using the BetaM 
model showed that female gender, older age, higher education 
level, being unemployed, ICU admission, and having diabetes 
had significant negative effects on the EQ-5D-5L index values 
(p < 0.05). The marginal effect analysis showed that the largest 
marginal effect was caused by age among the demographic 
variables (0.44), and having diabetes (0.31) among the clinical 
demographics (Table 3). 
Figure 1. Percentage of all COVID-19 patients admitted to hospital, 
who experienced HRQoL problems after hospital discharge (indicated 
by the EQ-5D-5L dimensions). 
EQ-5D-5L = EuroQol -5 dimensions - 5 levels; HRQoL = health-related 
quality of life.
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Discussion
This study evaluated HRQoL of COVID-19 patients using the 
EQ-5D-5L questionnaire and assessed the effects of socio-
demographic and clinical factors on HRQoL. The results of this 
study provided important insights of the HRQoL based on the 
characteristics of hospitalized COVID-19 patients that can be 
used in the management of the disease. The mean EQ-5D-5L 
score for the patients was 0.6125. 
A study conducted on people (n = 4,029) with suspected 
COVID-19 symptoms (S-COVID-19-S) visiting outpatient 
departments and health centers in Vietnam, in 2020 reported 
a mean score of 0.621 for the assessment of HRQoL [8]. The 
overall EQ-5D-5L score for COVID patients (0.612) in this 
study was lower than Asian patients suffering from diabetes 
(0.84) [21], type 2 diabetes (0.84) [22], cardiovascular diseases 
(0.84) [23], acute coronary syndrome (0.75) [24] human 
immunodeficiency virus (0.8) [25], skin diseases (0.73) [26], 
and respiratory diseases (0.66) [27], but higher than frail 
elderly (0.58) [28] and elderly patients after a fall injury (0.46) 
[29].
The percentage of individuals reporting problems affecting 
their HRQoL in each EQ-5D-5L dimension showed the most 
common problem was anxiety. Similar results also were 
reported by Nguyen et al [8]. They showed that the odds ratio 
of depression for people with S-COVID-19-S was higher than 
that of the people without S-COVID-19-S (3.69 vs. 1) [8].
Among the demographic factors, univariate analyses showed 
that the mean EQ-5D-5L scores were significantly different 
depending on gender, age, education level, employment status, 
and workplace of the patients. The findings were similar to 
the findings reported in the study by Nguyen et al [8]. They 
reported the difference between mean HRQoL scores for people 
with S-COVID-19-S was significant depending on age, gender, 
marital status, education level, occupation status, ability to pay 
for medication, social status, comorbidity, and physical activity 
[8]. 
The older age groups of patients had lower scores of HRQoL 
compared with the younger patients. This may reflect the 
fact that COVID-19 impacts more on older patients. Sommer 
et al [30] reported that severe cases of COVID-19 (involving 
ICU admission) skewed towards patients who were > 60 years 
old. This current study revealed that women had lower scores 
for HRQoL than men. This finding may be due to a difference 
in the level of physical activity between men and women in 
developing countries, as women have a lower level of physical 
EQ-5D-5L 
(dependent variable) Coef dy/dx SE z p 95% CI 
Gender
   Female -0.0898 -0.3216 0.0211 -4.25 0.035 [-0.1341 - 0.0642]
Age (y)
   41-50 0.0561 0.1981 0.0381 1.47 0.138 [0.0246 - 0.0916]
   51-60 -0.0811 -0.9212 0.0091 -8.91 <0.001 [-0.1290 - -0.0650]
   > 60 -0.1961 -01.041 0.0231 -8.49 <0.001 [-0.2188 - -0.1695]
Education status
   Primary -0.0420 -0.0123 0.0319 -1.31 0.429 [-0.1180 - -0.0412]
   Secondary -0.1052 -0.0751 0.0312 -3.37 0.098 [-0.1540 - -0.0715]
   University degree -0.1075 -0.0891 0.0208 -5.17 0.028 [-0.1367 - -0.0884]
   Unemployed -0.1020 -0.0323 0.0239 -4.26 0.029 [-0.1268 - -0.0580]
   ICU admission -0.2052 -0.0882 0.0372 -5.51 0.013 [-0.2280 - -0.1745]
   Diabetes -0.0875 -0.9812 0.0108 -8.10 <0.001 [-0.1074 - -0.0618]
   Heart failure -0.0724 -0.8723 0.0155 -4.67 0.026 [-0.0911 - -0.0329]
   Constant 1.2131 2.6783 0.0747 16.24 <0.001 [1.2043- 1.4972]
CI = confidence interval; Coef = coefficence; ICU = intensive care unit; EQ-5D-5L =EuroQol-5 dimensions-5 levels; SE =standard error.
Table 3. BetaMix regression analysis to determine EQ-5D-5L dependent variables associated with COVID-19 patients.
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activity than men [31]. Another reason may be due to the fact 
that women are more worried about disease and may have 
less ability to cope. It was also observed that the difference 
between mean HRQoL scores in patients with different levels 
of education was significant. Lower scores of HRQoL were 
observed in patients with a higher level of education a greater 
level of awareness and concern of COVID-19 and its impact 
on life. Nguyen et al [8] observed that people with a college/
university education had a higher prevalence of depression 
during the pandemic that created a burden of stress which 
further affected their HRQoL. The present study also showed 
that employed patients had higher scores of HRQoL. This 
could be due to the fact that the employed patients had not 
lost their income; therefore, they had more opportunity to 
have better healthcare [32]. A significant difference between 
HRQoL mean scores was also observed in workplaces of the 
patients. The patients who worked in crowded environments 
such as factories, shopping malls, and banks, had lower scores 
of HRQoL compared with people who worked in an uncrowded 
environment. The majority of the patients in crowded 
environments reported high anxiety of re-infection. We asked 
the patients to state their anxiety/depression regarding re-
infection using the 5-Likert scale (no anxiety, slight anxiety, 
some anxiety, a lot of anxiety, or very anxious/depressed). In 
contrast to the results of this study, executives in Chongqing, 
China (n = 122) were reported to have a lower prevalence of 
depression and anxiety when they returned to work during 
COVID-19 pandemic [33]. There is an urgency to redesign 
training programs and communication activities for a more 
effective dissemination of information related to the COVID-19 
[34].
Among clinical factors, the difference between mean scores 
of HRQoL was significant for ICU admission, having diabetes, 
and heart failure in this study. The mean HRQoL scores were 
different between the patients who had been admitted to 
hospital wards. The patients admitted to the ICU for COVID-19 
treatment had lower scores of HRQoL than those admitted to 
a hospital wards, probably because ICU patients experienced 
more severe problems related to COVID-19. The mean scores 
of HRQoL were lower in the patients with diabetes than 
those without diabetes. This is because the disease was more 
severe in the patients with diabetes and it exacerbates their 
diabetes symptoms [35]. These results are consistent with the 
findings of a recent study conducted in critical care COVID-19 
patients in the US. The study reported that COVID-19 in cases 
severe enough to require ICU admission, skewed the patient 
population towards patients with medical comorbidities, such 
as hypertension, diabetes mellitus, or cardiovascular diseases 
[30]. Furthermore, the patients with heart failure had lower 
HRQoL scores compared with those without heart failure. 
The regression analysis showed that amongst demographic 
factors, age had the most marginal effect therefore, it has 
the most impact on HRQoL. It can be explained by the direct 
relationship between aging and increasing incidence of 
problems in patients. Among the clinical factors, having 
diabetes had the most marginal effect on HRQoL. Diabetes has 
been reported as a comorbidity of COVID-19 [35]. 
One limitation of the study was that the design was not 
cross-sectional, which did not allow the determination of the 
exact effects of patients’ socio-demographic and clinical factors 
on HRQoL. Further research is required using a longitudinal 
study to understand how these factors may affect the HRQoL. 
Another limitation is the use of crosswalk to calculate the 
Iranian EQ-5D-5L value set. The value set based on crosswalk 
is less reliable than the one obtained directly from the general 
public-preference. However, crosswalk is currently the only 
available technique to generate the EQ-5D-5L value set for 
countries that do not have the EQ-5D-5L value set based on 
their own context.
Conclusion
The mean score of HRQoL for the patients was 0.6125 in this 
study. Identifying strategies to improve the HRQoL in patients, 
especially in aging and diabetic patients, is therefore of 
particular importance. This study showed that gender, among 
demographic factors, and diabetes, among clinical factors, had 
the most marginal effect on the dimensions of EQ-5D-5L. 
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